In addition to inhibiting TMPRSS2, preventing the processing of the spike protein and cellular entry of SARS-CoV-2, AAT has a panoply of other activities that could antagonize both the intracellular virus and the multiple pathogenic mechanisms associated with severe COVID-19 (Figure 2 and Table 1) [23,95]. Here, TMPRSS2 is linked to COVID-19.